A Mammalian Target of Rapamycin‐Perilipin 3 (mTORC1‐Plin3) Pathway is essential to Activate Lipophagy and Protects Against Hepatosteatosis. Issue 6 (21st September 2021)
- Record Type:
- Journal Article
- Title:
- A Mammalian Target of Rapamycin‐Perilipin 3 (mTORC1‐Plin3) Pathway is essential to Activate Lipophagy and Protects Against Hepatosteatosis. Issue 6 (21st September 2021)
- Main Title:
- A Mammalian Target of Rapamycin‐Perilipin 3 (mTORC1‐Plin3) Pathway is essential to Activate Lipophagy and Protects Against Hepatosteatosis
- Authors:
- Garcia‐Macia, Marina
Santos‐Ledo, Adrián
Leslie, Jack
Paish, Hannah L.
Collins, Amy L.
Scott, Rebecca S.
Watson, Abigail
Burgoyne, Rachel A.
White, Steve
French, Jeremy
Hammond, John
Borthwick, Lee A.
Mann, Jelena
Bolaños, Juan P.
Korolchuk, Viktor I.
Oakley, Fiona
Mann, Derek A. - Abstract:
- Abstract : Background and Aims: NAFLD is the most common hepatic pathology in western countries and no treatment is currently available. NAFLD is characterized by the aberrant hepatocellular accumulation of fatty acids in the form of lipid droplets (LDs). Recently, it was shown that liver LD degradation occurs through a process termed lipophagy, a form of autophagy. However, the molecular mechanisms governing liver lipophagy are elusive. Here, we aimed to ascertain the key molecular players that regulate hepatic lipophagy and their importance in NAFLD. Approach and Results: We analyzed the formation and degradation of LD in vitro (fibroblasts and primary mouse hepatocytes), in vivo and ex vivo (mouse and human liver slices) and focused on the role of the autophagy master regulator mammalian target of rapamycin complex (mTORC) 1 and the LD coating protein perilipin (Plin) 3 in these processes. We show that the autophagy machinery is recruited to the LD on hepatic overload of oleic acid in all experimental settings. This led to activation of lipophagy, a process that was abolished by Plin3 knockdown using RNA interference. Furthermore, Plin3 directly interacted with the autophagy proteins focal adhesion interaction protein 200 KDa and autophagy‐related 16L, suggesting that Plin3 functions as a docking protein or is involved in autophagosome formation to activate lipophagy. Finally, we show that mTORC1 phosphorylated Plin3 to promote LD degradation. Conclusions: These resultsAbstract : Background and Aims: NAFLD is the most common hepatic pathology in western countries and no treatment is currently available. NAFLD is characterized by the aberrant hepatocellular accumulation of fatty acids in the form of lipid droplets (LDs). Recently, it was shown that liver LD degradation occurs through a process termed lipophagy, a form of autophagy. However, the molecular mechanisms governing liver lipophagy are elusive. Here, we aimed to ascertain the key molecular players that regulate hepatic lipophagy and their importance in NAFLD. Approach and Results: We analyzed the formation and degradation of LD in vitro (fibroblasts and primary mouse hepatocytes), in vivo and ex vivo (mouse and human liver slices) and focused on the role of the autophagy master regulator mammalian target of rapamycin complex (mTORC) 1 and the LD coating protein perilipin (Plin) 3 in these processes. We show that the autophagy machinery is recruited to the LD on hepatic overload of oleic acid in all experimental settings. This led to activation of lipophagy, a process that was abolished by Plin3 knockdown using RNA interference. Furthermore, Plin3 directly interacted with the autophagy proteins focal adhesion interaction protein 200 KDa and autophagy‐related 16L, suggesting that Plin3 functions as a docking protein or is involved in autophagosome formation to activate lipophagy. Finally, we show that mTORC1 phosphorylated Plin3 to promote LD degradation. Conclusions: These results reveal that mTORC1 regulates liver lipophagy through a mechanism dependent on Plin3 phosphorylation. We propose that stimulating this pathway can enhance lipophagy in hepatocytes to help protect the liver from lipid‐mediated toxicity, thus offering a therapeutic strategy in NAFLD. … (more)
- Is Part Of:
- Hepatology. Volume 74:Issue 6(2021)
- Journal:
- Hepatology
- Issue:
- Volume 74:Issue 6(2021)
- Issue Display:
- Volume 74, Issue 6 (2021)
- Year:
- 2021
- Volume:
- 74
- Issue:
- 6
- Issue Sort Value:
- 2021-0074-0006-0000
- Page Start:
- 3441
- Page End:
- 3459
- Publication Date:
- 2021-09-21
- Subjects:
- Heart -- Diseases -- Nursing -- Periodicals
Lungs -- Diseases -- Nursing -- Periodicals
Intensive care nursing -- Periodicals
Foie -- Maladies -- Périodiques
616.362 - Journal URLs:
- http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)1527-3350 ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.1002/hep.32048 ↗
- Languages:
- English
- ISSNs:
- 0270-9139
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 4295.836000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 26703.xml